Screener
Thermo Fisher Scientific TMO Life Sciences Solutions — Restructuring and other costs
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept tmo:RestructuringAndOtherCostsIncomeNet.
The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 11:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000097745-26-000092
FAQ
- What is Thermo Fisher Scientific's life sciences solutions — restructuring and other costs?
- Thermo Fisher Scientific (TMO) reported life sciences solutions — restructuring and other costs of $9M in Q1 2026.
- What is the long-term trend for Thermo Fisher Scientific's life sciences solutions — restructuring and other costs?
- Over 3 years (2021 to 2024), Thermo Fisher Scientific's life sciences solutions — restructuring and other costs has grown at a -18.8% compound annual growth rate (CAGR), from $129M to $69M.
- What does life sciences solutions — restructuring and other costs mean?
- Expenses incurred by the Life Sciences Solutions segment related to organizational changes, such as facility consolidations, workforce reductions, or integration of acquired entities. These costs are typically non-recurring and aimed at improving long-term operational efficiency.
Ask your AI about Thermo Fisher Scientific's life sciences solutions — restructuring and other costs.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude